Redefining clinical trials: the age of personalized medicine

Cell. 2012 Mar 16;148(6):1079-80. doi: 10.1016/j.cell.2012.02.041.

Abstract

The triumph of personalized cancer therapeutics in recent years is prompting some oncologists to rethink clinical trial design; other researchers have different priorities for trial reform.

MeSH terms

  • Clinical Trials as Topic*
  • Crizotinib
  • Genome-Wide Association Study
  • Humans
  • Lung Neoplasms / drug therapy
  • Neoplasms / drug therapy*
  • Precision Medicine*
  • Pyrazoles / therapeutic use
  • Pyridines / therapeutic use
  • Randomized Controlled Trials as Topic

Substances

  • Pyrazoles
  • Pyridines
  • Crizotinib